These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7474915)

  • 21. [Accelerated amyloid formation in mice through spleen cell cultures].
    Jakob W; Hilgenfeld M; Karasek E
    Exp Pathol (Jena); 1972; 6(3):141-4. PubMed ID: 5050669
    [No Abstract]   [Full Text] [Related]  

  • 22. Apolipoprotein E and Alzheimer disease.
    Huang Y
    Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The scavenger receptor and its importance in amyloid processes].
    Aguilar-Gaytán R; Mas-Oliva J
    Gac Med Mex; 2002; 138(5):445-60. PubMed ID: 12404727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artificial production of amyloid in liver and spleen of Funambulus pennanti (Wroughton).
    Rana SV
    Anat Anz; 1972; 130(3):375-7. PubMed ID: 5025888
    [No Abstract]   [Full Text] [Related]  

  • 25. Amyloid at the cutting edge: activation of alpha-secretase prevents amyloidogenesis in an Alzheimer disease mouse model.
    Lichtenthaler SF; Haass C
    J Clin Invest; 2004 May; 113(10):1384-7. PubMed ID: 15146234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity.
    Maezawa I; Jin LW; Woltjer RL; Maeda N; Martin GM; Montine TJ; Montine KS
    J Neurochem; 2004 Dec; 91(6):1312-21. PubMed ID: 15584908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoE: new risk factor for Alzheimer's.
    Butler RN
    Geriatrics; 1994 Aug; 49(8):10-1. PubMed ID: 8039724
    [No Abstract]   [Full Text] [Related]  

  • 29. Transgenic mouse model of familial amyloidotic polyneuropathy type I: its production, biological features, and usefulness.
    Yi S; Takahashi K; Araki S; Yamamura K
    Lab Anim Sci; 1995 Apr; 45(2):173-5. PubMed ID: 7603019
    [No Abstract]   [Full Text] [Related]  

  • 30. A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits.
    Yamada T; Kakihara T; Gejyo F; Okada M
    Ann Clin Lab Sci; 1994; 24(3):243-9. PubMed ID: 8048796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further characterization of a monoclonal antibody recognizing apolipoprotein E peptides in amyloid deposits.
    Yamada T; Wakabayashi K; Kakihara T; Gejyo F; Takahashi H; Itoh Y
    Ann Clin Lab Sci; 1997; 27(4):276-81. PubMed ID: 9210972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E and beta A4-amyloid: signals and effects.
    Ohm TG; Hamker U; Cedazo-Minguez A; Röckl W; Scharnagl H; März W; Cowburn R; Müller W; Meske V
    Biochem Soc Symp; 2001; (67):121-9. PubMed ID: 11447828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E, A beta, and Alzheimer disease.
    Hyman BT; Terry RD
    J Neuropathol Exp Neurol; 1994 Sep; 53(5):427-8. PubMed ID: 8083685
    [No Abstract]   [Full Text] [Related]  

  • 34. [Apolipoprotein E and its receptors in Alzheimer's disease].
    Ikeda K
    Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1465-9. PubMed ID: 8741398
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.
    Bales KR; Verina T; Dodel RC; Du Y; Altstiel L; Bender M; Hyslop P; Johnstone EM; Little SP; Cummins DJ; Piccardo P; Ghetti B; Paul SM
    Nat Genet; 1997 Nov; 17(3):263-4. PubMed ID: 9354781
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inhibition of amyloidogenesis with Congo red in experimental amyloidosis].
    Kagan DZ; Rozinova VN
    Probl Tuberk; 1974; (9):72-4. PubMed ID: 4409858
    [No Abstract]   [Full Text] [Related]  

  • 37. [Symposium on amyloidosis among the Japanese. 5. Experimental amyloidosis and mechanism of amyloid substance production].
    Tsubura E
    Nihon Naika Gakkai Zasshi; 1972 Jul; 61(7):769-72. PubMed ID: 4675101
    [No Abstract]   [Full Text] [Related]  

  • 38. Apolipoprotein E4 is associated with primary localized cutaneous amyloidosis.
    Furumoto H; Hashimoto Y; Muto M; Shimizu T; Nakamura K
    J Invest Dermatol; 2002 Aug; 119(2):532-3. PubMed ID: 12190881
    [No Abstract]   [Full Text] [Related]  

  • 39. [Amyloid induction by chondroitin sulfate].
    Schmitz-Moormann P
    Virchows Arch A Pathol Pathol Anat; 1969; 348(2):131-8. PubMed ID: 4187154
    [No Abstract]   [Full Text] [Related]  

  • 40. The pathogenesis of amyloidosis: understanding general principles.
    Westermark P
    Am J Pathol; 1998 May; 152(5):1125-7. PubMed ID: 9588878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.